CorneaGen raises $37M in Series B funding round

CorneaGen focuses on innovating technologies to cure corneal blindness by 2040 and provides donor tissues for cornea transplants.

Source: bizjournals.com Health Care:Biotechnology headlines - October 8, 2019 Category: Biotechnology Authors: Megan Campbell Source Type: news